Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Global, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal™ Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early & Advanced Stage Superficial Venous Disease

NCT03820947 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT03820947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03820947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Global, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal™ Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early & Advanced Stage Superficial Venous Disease
Lead sponsor
Medtronic Endovascular
Phase
Not applicable
Overall status
Terminated
Start date
February 5, 2020
Completion date
November 10, 2025
Enrollment
506 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

venous reflux